Autoinjectors Market Size

Autoinjectors Market Size

Autoinjectors Market size was valued at over USD 55 billion in 2022 and is projected to register over 13% CAGR between 2023 and 2032. Rising prevalence of chronic diseases, growing demand for self-injection devices, and advancements in technology are some of the factors contributing to global market growth.

The increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis has also escalated the demand for autoinjectors. These conditions often require regular injections, and autoinjectors offer a safe and effective way to deliver these medications. According to the International Diabetes Federation (IDF), in 2021, approximately 537 million people worldwide had diabetes, and this number is expected to rise significantly in upcoming years. The IDF also estimated that nearly 50% of people with diabetes are undiagnosed, so the actual number of people living with diabetes may be higher than reported. Since, the majority are residing in low- and middle-income nations, and diabetes is directly responsible for 1.5 million annual deaths. Therefore, the growing importance of preventive care in developed and developing economies will spur autoinjectors market statistics.

An autoinjector is a medical device used for the administration of a specific dose of a medication, typically via injection. It is designed to be easy to use by the patient or caregiver and typically consists of a pre-filled syringe, a needle, and a spring-loaded mechanism that delivers the medication quickly and easily with the press of a button. Autoinjectors are commonly used to treat conditions such as allergies, arthritis, and multiple sclerosis, among others. They are often used in emergency situations where rapid administration of medication is necessary, and they can help reduce the risk of accidental needle stick injuries.